CAR T cells armed with IL-15 show promise in treating solid cancers
Researchers report results of the first-in-human phase 1 clinical trials of a novel immunotherapy approach for solid tumors expressing glypican-3 (GPC3). A team from Baylor College of Medicine and Texas Children’s Cancer Center led the […]